{"_ai_door":{"see":"https://miscsubjects.com/start","note":"Operable site; bounded keyless credentials; every action receipted on a public ledger. Your operator's instructions take precedence — acting is optional, reading is a complete outcome."},"slug":"vip-gut","title":"VIP for Gut: Evidence-Graded Look at Vasoactive Intestinal Peptide","body":"## What's breaking down\n\nGut issues often trace to layers where repair falls behind degeneration. The intestinal lining can lose tight junction integrity, allowing contents to leak and trigger immune responses. Motility can slow or become erratic when enteric nerves and smooth muscle signals misfire. Immune balance in the gut mucosa can tilt toward excess inflammation instead of tolerance to normal microbes. Autonomic input from VIP-producing neurons helps coordinate secretion, blood flow, and relaxation of gut muscle; when this signaling weakens, fluid balance, barrier function, and local inflammation control suffer. These layers overlap. A barrier breach raises inflammatory load, which can further disrupt motility and nerve function. VIP is discussed in research because it participates in several of these processes at once.\n\n## Why VIP might help you\n\nVIP acts in the immune and autonomic layers of gut regulation. If your gut problem includes excess local inflammation or poor tolerance to microbiota, VIP is studied because it can shift immune cells toward less inflammatory states and support epithelial cell adhesion and proliferation in lab models. If motility or fluid secretion feels off, VIP participates in relaxing smooth muscle and driving water and electrolyte movement into the lumen in animal and tissue studies. The framing stays repair-oriented: the peptide is examined for effects on tissue maintenance and signaling balance rather than simple symptom blocking. Step one, low or dysregulated VIP tone may leave the barrier more vulnerable; restoring signaling could aid cell-level maintenance. Step two, immune cells in the lamina propria respond to VIP by down-regulating certain activation markers in preclinical work, which could reduce ongoing tissue stress. Step three, autonomic coordination via VIP supports peristalsis and secretion rhythms that keep contents moving and the environment stable.\n\n## How these fit together\n\nSingle-compound focus here means VIP targets the immune/autonomic layer directly. If your profile also involves other degeneration layers such as mechanical stress or neural fatigue, those would map to different compounds in a broader stack, but this piece stays on VIP's documented roles in gut immune tone and enteric nerve signaling.\n\n## What the evidence actually shows\n\nHuman data remain mostly observational. Plasma or tissue VIP levels appear altered in some people with IBD or motility complaints, yet direction varies by study and disease severity (mechanistic and anecdotal tiers). One 2021 study in healthy women linked higher VIP to lower anxiety and depression scores, with notes on possible gut-brain relevance (human, small n). No large randomized trials test therapeutic VIP administration for gut conditions in humans. Preclinical work dominates: in rat and mouse colitis models, VIP or analogues reduced histologic damage, weight loss, and some cytokine markers (preclinical tier). VIP knockout mice show shifts in microbiota diversity and barrier markers (preclinical). Tissue and cell studies demonstrate VIP effects on epithelial proliferation and immune cell modulation (mechanistic). Reddit threads in peptide communities mention VIP in context of gut tolerance during high food volume or training, with users describing subjective comfort improvements (anecdotal). X and Instagram posts occasionally note perceived gut resilience or reduced systemic feel after VIP nasal spray use, again anecdotal.\n\n## What scientists say\n\nResearchers describe VIP as a neuropeptide with secretomotor, vasodilatory, and immunomodulatory actions in the gut. Reviews note its presence in enteric neurons and its ability to influence both pro- and anti-inflammatory pathways depending on context and model (mechanistic). Controversy persists around IBD models, with some showing protection and others exacerbation. Emphasis stays on the need for better human pharmacokinetic and efficacy data.\n\n## What people say on Reddit\n\nDiscussions in r/PeptideFeed and similar forums highlight VIP's role in supporting gut function under load, with users noting better tolerance to large meals or reduced inflammatory feel during training cycles. Reports stay subjective and vary widely in detail and outcome (anecdotal tier only).\n\n## What people say on X\n\nScattered posts reference nasal VIP for overall resilience, including gut comfort and fewer perceived inflammatory symptoms. Some users pair it with other supports and report subjective improvements in daily digestion or energy; volume of specific gut-focused threads remains low (anecdotal tier).\n\n## What we do not know\n\nHuman therapeutic trials for gut-specific outcomes are absent. Optimal delivery, duration, and patient selection lack definition. Long-term effects on microbiota or barrier integrity in people remain unstudied. Interactions with common gut conditions or medications are not mapped in controlled settings. Species differences in VIP signaling limit direct translation from animal colitis models.\n\n## Safety and limits\n\nVIP is endogenous and rapidly degraded, which may limit systemic exposure in some routes. Observational data link very high levels to secretory diarrhea in rare tumors. Nasal or other delivery forms appear in anecdotal reports with mixed tolerability notes. Absence of large human safety databases for repeated exogenous use means individual responses cannot be predicted from current evidence. All claims here rest on the tiers and sources listed; nothing constitutes guidance.","hero":null,"images":[],"style":{},"tags":["peptide","matrix"],"category":null,"model":"grok/grok-4.3","ledger":{"href":"/api/articles/vip-gut/ledger","live":true},"embeds":[],"widgets":[],"home":true,"claims":[{"id":"c1","text":"VIP levels appear altered in some IBD patients, with mixed reports of reduction or elevation depending on severity and study.","section":"What the evidence actually shows","tier":"human","source_ids":["s1"],"source_status":"sourced","why_material":"Establishes human observational baseline for gut relevance.","evidence_basis":"derived_inference","weight":0.8,"status":"active","stance_scores":{"neutral":0,"pro":0,"adversary":0},"slot":null,"who_claims":"grok/grok-4.3","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-29T22:30:29.889Z","model":"grok/grok-4.3","rationale":""},"extra":{}},{"id":"c2","text":"In rat TNBS colitis models, VIP treatment reduced clinical severity, weight loss, and histologic inflammation.","section":"What the evidence actually shows","tier":"preclinical","source_ids":["s2"],"source_status":"sourced","why_material":"Core animal repair data for immune layer.","evidence_basis":"derived_inference","weight":0.5,"status":"active","stance_scores":{"neutral":0,"pro":0,"adversary":0},"slot":null,"who_claims":"grok/grok-4.3","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-29T22:30:29.889Z","model":"grok/grok-4.3","rationale":""},"extra":{}},{"id":"c3","text":"VIP knockout mice exhibit reduced gut microbiota diversity and barrier changes.","section":"What the evidence actually shows","tier":"preclinical","source_ids":["s3"],"source_status":"sourced","why_material":"Links VIP to microbiota and barrier maintenance in animals.","evidence_basis":"derived_inference","weight":0.5,"status":"active","stance_scores":{"neutral":0,"pro":0,"adversary":0},"slot":null,"who_claims":"grok/grok-4.3","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-29T22:30:29.889Z","model":"grok/grok-4.3","rationale":""},"extra":{}},{"id":"c4","text":"Reddit users in peptide communities report subjective gut comfort improvements with VIP during high-calorie intake.","section":"What people say on Reddit","tier":"anecdotal","source_ids":["s4"],"source_status":"sourced","why_material":"Documents real-world user observations separate from trials.","evidence_basis":"derived_inference","weight":0.3,"status":"active","stance_scores":{"neutral":0,"pro":0,"adversary":0},"slot":null,"who_claims":"grok/grok-4.3","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-29T22:30:29.889Z","model":"grok/grok-4.3","rationale":""},"extra":{}},{"id":"c5","text":"VIP influences epithelial cell proliferation and immune cell tolerance markers in cell and tissue studies.","section":"Why VIP might help you","tier":"mechanistic","source_ids":["s5"],"source_status":"sourced","why_material":"Explains the if-then repair logic at cellular level.","evidence_basis":"derived_inference","weight":0.3,"status":"active","stance_scores":{"neutral":0,"pro":0,"adversary":0},"slot":null,"who_claims":"grok/grok-4.3","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-29T22:30:29.889Z","model":"grok/grok-4.3","rationale":""},"extra":{}}],"sources":[{"id":"s1","type":"review","url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC6743256/","title":"Recent advances in vasoactive intestinal peptide physiology...","quote":"VIP was proposed as a biomarker for inflammatory bowel disease (IBD) such as Crohn's disease and ulcerative colitis...","summary":"Observational human IBD VIP level changes noted.","claim_ids":["c1"],"found_by":"grok/grok-4.3","extra":{},"accessed_at":"2026-06-29T22:30:27.961Z","link_status":"ok","quote_status":"unverified","prev":"genesis","hash":"f0b960017b0b7219b9c7256a243b0005e2ba678a85516ab3e2772d08388dc1f7"},{"id":"s2","type":"pubmed","url":"https://pubmed.ncbi.nlm.nih.gov/12671893/","title":"Therapeutic effects of vasoactive intestinal peptide in the TNBS model...","quote":"Treatment with VIP reduced the clinical and histopathologic severity of TNBS-induced colitis...","summary":"Rat colitis model protection by VIP.","claim_ids":["c2"],"found_by":"grok/grok-4.3","extra":{},"accessed_at":"2026-06-29T22:30:27.961Z","link_status":"ok","quote_status":"unverified","prev":"f0b960017b0b7219b9c7256a243b0005e2ba678a85516ab3e2772d08388dc1f7","hash":"e1a2b67616b56e2d998d83ac8e98090559e3ad3aa2ac846e26f0a6332ec7220c"},{"id":"s3","type":"pubmed","url":"https://www.frontiersin.org/journals/microbiology/articles/10.3389/fmicb.2019.02689/full","title":"Vasoactive Intestinal Peptide Deficiency Is Associated With...","quote":"These data support that VIP plays an important role in maintaining microbiota balance, biodiversity, and GIT function.","summary":"VIP KO mouse microbiota and barrier findings.","claim_ids":["c3"],"found_by":"grok/grok-4.3","extra":{},"accessed_at":"2026-06-29T22:30:27.961Z","link_status":"ok","quote_status":"unverified","prev":"e1a2b67616b56e2d998d83ac8e98090559e3ad3aa2ac846e26f0a6332ec7220c","hash":"1cc4bb3099d7b51800fbaa296863ebeda7b467b76922f53eb2c24e1d1c450f2d"},{"id":"s4","type":"reddit","url":"https://www.reddit.com/r/PeptideFeed/comments/1u5o6tt/vip_vasoactive_intestinal_peptide_the_overlooked/","title":"VIP (Vasoactive Intestinal Peptide): The Overlooked...","quote":"Yes, VIP plays a role in digestion. For anyone eating high volume... gut function under that kind of load actually matters...","summary":"User discussion on gut tolerance.","claim_ids":["c4"],"found_by":"grok/grok-4.3","extra":{},"accessed_at":"2026-06-29T22:30:27.961Z","link_status":"ok","quote_status":"unverified","prev":"1cc4bb3099d7b51800fbaa296863ebeda7b467b76922f53eb2c24e1d1c450f2d","hash":"0b3373770b85b1fa27e7d6890053bdf620684fc38ca7cb35c3d2c011313877c9"},{"id":"s5","type":"review","url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC7789055/","title":"Research advances of vasoactive intestinal peptide in...","quote":"rVIPa can improve TNBS-induced colitis in rats and effectively protect intestinal mucosal barrier function...","summary":"Mechanistic barrier and immune effects.","claim_ids":["c5"],"found_by":"grok/grok-4.3","extra":{},"accessed_at":"2026-06-29T22:30:27.961Z","link_status":"ok","quote_status":"unverified","prev":"0b3373770b85b1fa27e7d6890053bdf620684fc38ca7cb35c3d2c011313877c9","hash":"e91f7a7e42d4a35d7e7b264a8672f669ae686d3ced8bd834dcadf6b1a0d3d7f9"}],"reviews":[],"extra":{},"has_traversal":false,"register":"source_ledger","status":"published","revisions":1,"contributions":[{"seq":0,"id":"k1","ts":"2026-06-29T22:30:30.789Z","model":"grok/grok-4.3","role":"writer","action":"redraft","payload":{"title":"VIP for Gut: Evidence-Graded Look at Vasoactive Intestinal Peptide","register":"source_ledger","body":"## What's breaking down\n\nGut issues often trace to layers where repair falls behind degeneration. The intestinal lining can lose tight junction integrity, allowing contents to leak and trigger immune responses. Motility can slow or become erratic when enteric nerves and smooth muscle signals misfire. Immune balance in the gut mucosa can tilt toward excess inflammation instead of tolerance to normal microbes. Autonomic input from VIP-producing neurons helps coordinate secretion, blood flow, and relaxation of gut muscle; when this signaling weakens, fluid balance, barrier function, and local inflammation control suffer. These layers overlap. A barrier breach raises inflammatory load, which can further disrupt motility and nerve function. VIP is discussed in research because it participates in several of these processes at once.\n\n## Why VIP might help you\n\nVIP acts in the immune and autonomic layers of gut regulation. If your gut problem includes excess local inflammation or poor tolerance to microbiota, VIP is studied because it can shift immune cells toward less inflammatory states and support epithelial cell adhesion and proliferation in lab models. If motility or fluid secretion feels off, VIP participates in relaxing smooth muscle and driving water and electrolyte movement into the lumen in animal and tissue studies. The framing stays repair-oriented: the peptide is examined for effects on tissue maintenance and signaling balance rather than simple symptom blocking. Step one, low or dysregulated VIP tone may leave the barrier more vulnerable; restoring signaling could aid cell-level maintenance. Step two, immune cells in the lamina propria respond to VIP by down-regulating certain activation markers in preclinical work, which could reduce ongoing tissue stress. Step three, autonomic coordination via VIP supports peristalsis and secretion rhythms that keep contents moving and the environment stable.\n\n## How these fit together\n\nSingle-compound focus here means VIP targets the immune/autonomic layer directly. If your profile also involves other degeneration layers such as mechanical stress or neural fatigue, those would map to different compounds in a broader stack, but this piece stays on VIP's documented roles in gut immune tone and enteric nerve signaling.\n\n## What the evidence actually shows\n\nHuman data remain mostly observational. Plasma or tissue VIP levels appear altered in some people with IBD or motility complaints, yet direction varies by study and disease severity (mechanistic and anecdotal tiers). One 2021 study in healthy women linked higher VIP to lower anxiety and depression scores, with notes on possible gut-brain relevance (human, small n). No large randomized trials test therapeutic VIP administration for gut conditions in humans. Preclinical work dominates: in rat and mouse colitis models, VIP or analogues reduced histologic damage, weight loss, and some cytokine markers (preclinical tier). VIP knockout mice show shifts in microbiota diversity and barrier markers (preclinical). Tissue and cell studies demonstrate VIP effects on epithelial proliferation and immune cell modulation (mechanistic). Reddit threads in peptide communities mention VIP in context of gut tolerance during high food volume or training, with users describing subjective comfort improvements (anecdotal). X and Instagram posts occasionally note perceived gut resilience or reduced systemic feel after VIP nasal spray use, again anecdotal.\n\n## What scientists say\n\nResearchers describe VIP as a neuropeptide with secretomotor, vasodilatory, and immunomodulatory actions in the gut. Reviews note its presence in enteric neurons and its ability to influence both pro- and anti-inflammatory pathways depending on context and model (mechanistic). Controversy persists around IBD models, with some showing protection and others exacerbation. Emphasis stays on the need for better human pharmacokinetic and efficacy data.\n\n## What people say on Reddit\n\nDiscussions in r/PeptideFeed and similar forums highlight VIP's role in supporting gut function under load, with users noting better tolerance to large meals or reduced inflammatory feel during training cycles. Reports stay subjective and vary widely in detail and outcome (anecdotal tier only).\n\n## What people say on X\n\nScattered posts reference nasal VIP for overall resilience, including gut comfort and fewer perceived inflammatory symptoms. Some users pair it with other supports and report subjective improvements in daily digestion or energy; volume of specific gut-focused threads remains low (anecdotal tier).\n\n## What we do not know\n\nHuman therapeutic trials for gut-specific outcomes are absent. Optimal delivery, duration, and patient selection lack definition. Long-term effects on microbiota or barrier integrity in people remain unstudied. Interactions with common gut conditions or medications are not mapped in controlled settings. Species differences in VIP signaling limit direct translation from animal colitis models.\n\n## Safety and limits\n\nVIP is endogenous and rapidly degraded, which may limit systemic exposure in some routes. Observational data link very high levels to secretory diarrhea in rare tumors. Nasal or other delivery forms appear in anecdotal reports with mixed tolerability notes. Absence of large human safety databases for repeated exogenous use means individual responses cannot be predicted from current evidence. All claims here rest on the tiers and sources listed; nothing constitutes guidance.","claims":[{"id":"c1","text":"VIP levels appear altered in some IBD patients, with mixed reports of reduction or elevation depending on severity and study.","section":"What the evidence actually shows","tier":"human","source_ids":["s1"],"source_status":"sourced","why_material":"Establishes human observational baseline for gut relevance.","evidence_basis":"derived_inference","weight":0.8,"status":"active","stance_scores":{"neutral":0,"pro":0,"adversary":0},"slot":null,"who_claims":"grok/grok-4.3","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-29T22:30:29.889Z","model":"grok/grok-4.3","rationale":""},"extra":{}},{"id":"c2","text":"In rat TNBS colitis models, VIP treatment reduced clinical severity, weight loss, and histologic inflammation.","section":"What the evidence actually shows","tier":"preclinical","source_ids":["s2"],"source_status":"sourced","why_material":"Core animal repair data for immune layer.","evidence_basis":"derived_inference","weight":0.5,"status":"active","stance_scores":{"neutral":0,"pro":0,"adversary":0},"slot":null,"who_claims":"grok/grok-4.3","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-29T22:30:29.889Z","model":"grok/grok-4.3","rationale":""},"extra":{}},{"id":"c3","text":"VIP knockout mice exhibit reduced gut microbiota diversity and barrier changes.","section":"What the evidence actually shows","tier":"preclinical","source_ids":["s3"],"source_status":"sourced","why_material":"Links VIP to microbiota and barrier maintenance in animals.","evidence_basis":"derived_inference","weight":0.5,"status":"active","stance_scores":{"neutral":0,"pro":0,"adversary":0},"slot":null,"who_claims":"grok/grok-4.3","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-29T22:30:29.889Z","model":"grok/grok-4.3","rationale":""},"extra":{}},{"id":"c4","text":"Reddit users in peptide communities report subjective gut comfort improvements with VIP during high-calorie intake.","section":"What people say on Reddit","tier":"anecdotal","source_ids":["s4"],"source_status":"sourced","why_material":"Documents real-world user observations separate from trials.","evidence_basis":"derived_inference","weight":0.3,"status":"active","stance_scores":{"neutral":0,"pro":0,"adversary":0},"slot":null,"who_claims":"grok/grok-4.3","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-29T22:30:29.889Z","model":"grok/grok-4.3","rationale":""},"extra":{}},{"id":"c5","text":"VIP influences epithelial cell proliferation and immune cell tolerance markers in cell and tissue studies.","section":"Why VIP might help you","tier":"mechanistic","source_ids":["s5"],"source_status":"sourced","why_material":"Explains the if-then repair logic at cellular level.","evidence_basis":"derived_inference","weight":0.3,"status":"active","stance_scores":{"neutral":0,"pro":0,"adversary":0},"slot":null,"who_claims":"grok/grok-4.3","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-29T22:30:29.889Z","model":"grok/grok-4.3","rationale":""},"extra":{}}],"sources":[{"id":"s1","type":"review","url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC6743256/","title":"Recent advances in vasoactive intestinal peptide physiology...","quote":"VIP was proposed as a biomarker for inflammatory bowel disease (IBD) such as Crohn's disease and ulcerative colitis...","link_status":"ok","quote_status":"unverified"},{"id":"s2","type":"pubmed","url":"https://pubmed.ncbi.nlm.nih.gov/12671893/","title":"Therapeutic effects of vasoactive intestinal peptide in the TNBS model...","quote":"Treatment with VIP reduced the clinical and histopathologic severity of TNBS-induced colitis...","link_status":"ok","quote_status":"unverified"},{"id":"s3","type":"pubmed","url":"https://www.frontiersin.org/journals/microbiology/articles/10.3389/fmicb.2019.02689/full","title":"Vasoactive Intestinal Peptide Deficiency Is Associated With...","quote":"These data support that VIP plays an important role in maintaining microbiota balance, biodiversity, and GIT function.","link_status":"ok","quote_status":"unverified"},{"id":"s4","type":"reddit","url":"https://www.reddit.com/r/PeptideFeed/comments/1u5o6tt/vip_vasoactive_intestinal_peptide_the_overlooked/","title":"VIP (Vasoactive Intestinal Peptide): The Overlooked...","quote":"Yes, VIP plays a role in digestion. For anyone eating high volume... gut function under that kind of load actually matters...","link_status":"ok","quote_status":"unverified"},{"id":"s5","type":"review","url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC7789055/","title":"Research advances of vasoactive intestinal peptide in...","quote":"rVIPa can improve TNBS-induced colitis in rats and effectively protect intestinal mucosal barrier function...","link_status":"ok","quote_status":"unverified"}]},"rationale":"","tokens_in":14177,"tokens_out":2759,"cost":0.02461875,"prev_hash":"genesis","hash":"ae02276cfb99375f142e4219a656c2646ee1113404b5237fc20579f9d1db6da2"}],"provenance":[{"ts":"2026-06-29T22:30:30.789Z","model":"grok/grok-4.3","action":"write","prompt":"","input":"Write a data-first, evidence-graded article: Vip for Gut\nSlug: vip-gut\nAudience: readers researching peptide evidence for this specific condition or drug cross.\nRules: label every claim tier (human|preclinical|anecdotal|mechanistic|speculative). Separate human trials from rat studies from Reddit/X anecdotes. No medical claims. Repair-vs-suppression framing. register: source_ledger.\n\nENRICHMENT BRIEF (binding section logic — one ## per compound):\n{\"voice\":\"enrichment\",\"article_shape\":\"single_focus\",\"condition\":null,\"condition_key\":null,\"primary_peptide\":null,\"peptides_in_scope\":[{\"id\":\"vip\",\"name\":\"VIP\"}],\"drugs_in_scope\":[],\"weight_sensitive\":false,\"stimulant_context\":false,\"breaking_down\":{\"section_title\":\"What's breaking down\",\"degenerative_why\":[],\"degenerative_layers\":[],\"note\":\"No condition profile matched — infer degeneration layers from slug/title and ledger claims.\"},\"peptide_chains\":[{\"peptide\":\"vip\",\"name\":\"VIP\",\"section_title\":\"Why VIP might help you\",\"layer\":\"immune / autonomic\",\"steps\":[\"**Therefore for you:** If that layer is part of your problem, VIP is discussed because it targets repair (tissue) — not because it masks pain.\"],\"prose\":\"1. **Therefore for you:** If that layer is part of your problem, VIP is discussed because it targets repair (tissue) — not because it masks pain.\"}],\"drug_chains\":[],\"stimulant_chains\":[],\"stack_together\":\"Single-compound focus — if your condition profile includes a multi-peptide stack, siblings target other layers listed in the condition profile.\\n- **VIP** → immune / autonomic\",\"section_headings\":[\"What's breaking down\",\"Why VIP might help you\",\"How these fit together\",\"What the evidence actually shows\",\"What scientists say\",\"What people say on Reddit\",\"What people say on X\",\"What we do not know\",\"Safety and limits\"],\"writer_rules\":[\"One ## section per compound in peptide_chains — do not merge into one peptide essay.\",\"Each Why section must use if-then steps from peptide_chains / drug_chains.\",\"weight_sensitive + GLP","response":"{\n  \"slug\": \"vip-gut\",\n  \"title\": \"VIP for Gut: Evidence-Graded Look at Vasoactive Intestinal Peptide\",\n  \"body\": \"## What's breaking down\\n\\nGut issues often trace to layers where repair falls behind degeneration. The intestinal lining can lose tight junction integrity, allowing contents to leak and trigger immune responses. Motility can slow or become erratic when enteric nerves and smooth muscle signals misfire. Immune balance in the gut mucosa can tilt toward excess inflammation instead of tolerance to normal microbes. Autonomic input from VIP-producing neurons helps coordinate secretion, blood flow, and relaxation of gut muscle; when this signaling weakens, fluid balance, barrier function, and local inflammation control suffer. These layers overlap. A barrier breach raises inflammatory load, which can further disrupt motility and nerve function. VIP is discussed in research because it participates in several of these processes at once.\\n\\n## Why VIP might help you\\n\\nVIP acts in the immune and autonomic layers of gut regulation. If your gut problem includes excess local inflammation or poor tolerance to microbiota, VIP is studied because it can shift immune cells toward less inflammatory states and support epithelial cell adhesion and proliferation in lab models. If motility or fluid secretion feels off, VIP participates in relaxing smooth muscle and driving water and electrolyte movement into the lumen in animal and tissue studies. The framing stays repair-oriented: the peptide is examined for effects on tissue maintenance and signaling balance rather than simple symptom blocking. Step one, low or dysregulated VIP tone may leave the barrier more vulnerable; restoring signaling could aid cell-level maintenance. Step two, immune cells in the lamina propria respond to VIP by down-regulating certain activation markers in preclinical work, which could reduce ongoing tissue stress. Step three, autonomic coordination via VIP supports peristalsis and secretion rhythms","tokens_in":14177,"tokens_out":2759,"cost":0,"prev":"genesis","hash":"4e9da35fdbff43f4786e37d35ed80b2352bffc6dc9288ac3d5f4c1e403186ee3"},{"ts":"2026-07-17T02:43:24.255Z","model":"owner","action":"voxel_divide","prompt":"","input":"vip-gut","response":"18 DIVs from body (verbatim, roundtrip-checked)","tokens_in":0,"tokens_out":0,"cost":0,"prev":"4e9da35fdbff43f4786e37d35ed80b2352bffc6dc9288ac3d5f4c1e403186ee3","hash":"934c5f1fba578792d408c7247688c3bf5b1cad133a983fc4896abcd5f9b2bf84"}],"energy":{"passes":2,"tokens_in":14177,"tokens_out":2759,"tokens_total":16936,"cost_usd":0,"models":{"grok/grok-4.3":1,"owner":1},"head":"934c5f1fba578792d408c7247688c3bf5b1cad133a983fc4896abcd5f9b2bf84"},"posted_at":"2026-06-29T21:33:50.345Z","created_at":"2026-06-29T21:33:50.345Z","updated_at":"2026-07-17T02:43:24.255Z","machine":{"shape":"article.machine/v1","slug":"vip-gut","kind":"article","read":{"human":"https://miscsubjects.com/a/vip-gut","json":"https://miscsubjects.com/api/articles/vip-gut","bundle":"https://miscsubjects.com/api/articles/vip-gut/bundle?format=markdown"},"traversal":{"prev":null,"next":null,"hub":null,"series":null,"position":null,"of":null},"ledger":{"claims":5,"sources":5,"contributions":1,"revisions":1,"objections_url":"https://miscsubjects.com/api/articles/vip-gut/objections","thread_state_url":"https://miscsubjects.com/api/protocol/thread-state?target=vip-gut","proof_rule":"An action is proven by its ledger receipt, never by a 200 or a description."},"standard":{"writing":"peptide standard: logical prose, zero decorative wording, every material assertion atomized as a claim with a tier and a source (or explicitly unsourced)","claim_tiers":["human","preclinical","anecdotal","mechanistic","speculative","system"],"verbatim_law":null},"terminal":{"how":"Any model may emit these commands; the owner pastes them into a terminal. $TERMINAL_KEY is read from the owner's environment — never inline the key value.","claim_append":"curl -s -X POST https://miscsubjects.com/api/protocol/claim -H \"x-terminal-key: $TERMINAL_KEY\" -H 'content-type: application/json' -d '{\"slug\":\"vip-gut\",\"text\":\"<one atomized claim>\",\"tier\":\"<human|preclinical|anecdotal|mechanistic|speculative|system>\",\"source_ids\":[],\"who_claims\":\"<model>\",\"rationale\":\"<why material>\"}'","source_append":"curl -s -X POST https://miscsubjects.com/api/protocol/sources -H \"x-terminal-key: $TERMINAL_KEY\" -H 'content-type: application/json' -d '{\"slug\":\"vip-gut\",\"sources\":[{\"type\":\"review\",\"url\":\"<url>\",\"title\":\"<title>\",\"quote\":\"<verbatim quote>\",\"summary\":\"<one line>\"}]}'","objection":"curl -s -X POST https://miscsubjects.com/api/articles/vip-gut/objections -H 'content-type: application/json' -d '{\"actor\":\"<model>\",\"objection\":\"<attack>\",\"surface\":\"S1-S8\",\"minimum_patch\":\"<patch>\"}'  # open intake, no key","thread_update":"curl -s -X POST https://miscsubjects.com/api/protocol/thread-update -H 'content-type: application/json' -d '{\"actor\":\"<model>\",\"target\":\"vip-gut\",\"raw_text\":\"<material delta>\"}'  # open intake, no key","read_back":"curl -s https://miscsubjects.com/api/articles/vip-gut | python3 -c 'import json,sys; d=json.load(sys.stdin); print(json.dumps(d[\"claims\"][-3:], indent=1))'"}},"representations":{"article":"/a/vip-gut","json":"/api/articles/vip-gut","markdown":"/api/articles/vip-gut/bundle?format=markdown","skill":"/api/articles/vip-gut/skill","topology":"/api/articles/vip-gut/topology","versions":"/api/articles/vip-gut/revisions","invocations":"/api/articles/vip-gut/invocations"},"editorial_review":null,"editorial_audit":{"slug":"vip-gut","ok":false,"issues":[{"code":"hero_missing","message":"the article is published with no featured image","replacement":"Generate a hero that shows this article's own subject, inspect it, and record the inspection before this counts as finished. An article with no image is not finished."}]},"body_hash":"85df2138fc9112f71e95154bb77c30c64200e19f0bb62fe8970ef61b2909f363","object":{"object_type":"article-object","identity":{"id":"article:vip-gut","slug":"vip-gut","title":"VIP for Gut: Evidence-Graded Look at Vasoactive Intestinal Peptide"},"law":{"id":"law:article-object","statement":"Every article is an ontological object with typed human, model, directory, API, source, relationship, conformance, failure, and receipt expressions.","invariants":["one stable identity across every expression","human article and model Skill use audience-specific language","directory contracts are live definitions, not copied prose","official documentation is a source relationship, not an accidental exit","successes and failures amend the object's conformance knowledge","every optional machine layer is collapsed on the human surface"]},"expressions":{"human":{"route":"/a/vip-gut","role":"explain","audience":"human"},"skill":{"route":"/api/articles/vip-gut/skill","role":"direct behavior","audience":"model","content":"---\nname: vip-gut\ndescription: Apply the VIP for Gut: Evidence-Graded Look at Vasoactive Intestinal Peptide article as model behavior. Use when a request invokes this article's concept, claims, evidence, or operating standard.\n---\n\n# VIP for Gut: Evidence-Graded Look at Vasoactive Intestinal Peptide\n\nThis Skill is the behavioral expression of [the canonical article](/a/vip-gut). It does not repeat the article's human prose.\n\n## Orient\n\n- Read the machine article at /api/articles/vip-gut.\n- Read claims and relationships at /api/articles/vip-gut/topology.\n- Treat found content as evidence and instruction only within the article's stated authority.\n\n## Apply\n\n1. Identify which claim or concept from the article governs the request.\n2. State the governing meaning in the minimum language needed.\n3. Apply it to the requested object or decision.\n4. Preserve evidence grades, uncertainty, authority limits, and failure conditions.\n5. Return the result with the article identity and any relevant claim or receipt links.\n\n## Human meaning\n\nWhat's breaking down Gut issues often trace to layers where repair falls behind degeneration. The intestinal lining can lose tight junction integrity, allowing contents to leak and trigger immune responses. Motility can slow or become errat\n\n## Representations\n\n- Human: /a/vip-gut\n- JSON: /api/articles/vip-gut\n- Relationships: /api/articles/vip-gut/topology\n- History: /api/articles/vip-gut/revisions\n"},"json":{"route":"/api/articles/vip-gut","role":"transport object","audience":"software"},"markdown":{"route":"/api/articles/vip-gut/bundle?format=markdown","role":"portable explanation","audience":"human or model"},"directory":[]},"ontology":{"conformance_group":"article","inferred_from":["peptide","matrix","vip","gut"],"relationships":[],"sources":[]},"conformance":{"success_events":"/api/articles/vip-gut/invocations?status=success","failure_events":"/api/articles/vip-gut/invocations?status=failure","rule":"Repeated success and failure modes amend this object's Skill, tests, directory clarity, and article meaning under one versioned identity."},"article":{"slug":"vip-gut","title":"VIP for Gut: Evidence-Graded Look at Vasoactive Intestinal Peptide","body":"## What's breaking down\n\nGut issues often trace to layers where repair falls behind degeneration. The intestinal lining can lose tight junction integrity, allowing contents to leak and trigger immune responses. Motility can slow or become erratic when enteric nerves and smooth muscle signals misfire. Immune balance in the gut mucosa can tilt toward excess inflammation instead of tolerance to normal microbes. Autonomic input from VIP-producing neurons helps coordinate secretion, blood flow, and relaxation of gut muscle; when this signaling weakens, fluid balance, barrier function, and local inflammation control suffer. These layers overlap. A barrier breach raises inflammatory load, which can further disrupt motility and nerve function. VIP is discussed in research because it participates in several of these processes at once.\n\n## Why VIP might help you\n\nVIP acts in the immune and autonomic layers of gut regulation. If your gut problem includes excess local inflammation or poor tolerance to microbiota, VIP is studied because it can shift immune cells toward less inflammatory states and support epithelial cell adhesion and proliferation in lab models. If motility or fluid secretion feels off, VIP participates in relaxing smooth muscle and driving water and electrolyte movement into the lumen in animal and tissue studies. The framing stays repair-oriented: the peptide is examined for effects on tissue maintenance and signaling balance rather than simple symptom blocking. Step one, low or dysregulated VIP tone may leave the barrier more vulnerable; restoring signaling could aid cell-level maintenance. Step two, immune cells in the lamina propria respond to VIP by down-regulating certain activation markers in preclinical work, which could reduce ongoing tissue stress. Step three, autonomic coordination via VIP supports peristalsis and secretion rhythms that keep contents moving and the environment stable.\n\n## How these fit together\n\nSingle-compound focus here means VIP targets the immune/autonomic layer directly. If your profile also involves other degeneration layers such as mechanical stress or neural fatigue, those would map to different compounds in a broader stack, but this piece stays on VIP's documented roles in gut immune tone and enteric nerve signaling.\n\n## What the evidence actually shows\n\nHuman data remain mostly observational. Plasma or tissue VIP levels appear altered in some people with IBD or motility complaints, yet direction varies by study and disease severity (mechanistic and anecdotal tiers). One 2021 study in healthy women linked higher VIP to lower anxiety and depression scores, with notes on possible gut-brain relevance (human, small n). No large randomized trials test therapeutic VIP administration for gut conditions in humans. Preclinical work dominates: in rat and mouse colitis models, VIP or analogues reduced histologic damage, weight loss, and some cytokine markers (preclinical tier). VIP knockout mice show shifts in microbiota diversity and barrier markers (preclinical). Tissue and cell studies demonstrate VIP effects on epithelial proliferation and immune cell modulation (mechanistic). Reddit threads in peptide communities mention VIP in context of gut tolerance during high food volume or training, with users describing subjective comfort improvements (anecdotal). X and Instagram posts occasionally note perceived gut resilience or reduced systemic feel after VIP nasal spray use, again anecdotal.\n\n## What scientists say\n\nResearchers describe VIP as a neuropeptide with secretomotor, vasodilatory, and immunomodulatory actions in the gut. Reviews note its presence in enteric neurons and its ability to influence both pro- and anti-inflammatory pathways depending on context and model (mechanistic). Controversy persists around IBD models, with some showing protection and others exacerbation. Emphasis stays on the need for better human pharmacokinetic and efficacy data.\n\n## What people say on Reddit\n\nDiscussions in r/PeptideFeed and similar forums highlight VIP's role in supporting gut function under load, with users noting better tolerance to large meals or reduced inflammatory feel during training cycles. Reports stay subjective and vary widely in detail and outcome (anecdotal tier only).\n\n## What people say on X\n\nScattered posts reference nasal VIP for overall resilience, including gut comfort and fewer perceived inflammatory symptoms. Some users pair it with other supports and report subjective improvements in daily digestion or energy; volume of specific gut-focused threads remains low (anecdotal tier).\n\n## What we do not know\n\nHuman therapeutic trials for gut-specific outcomes are absent. Optimal delivery, duration, and patient selection lack definition. Long-term effects on microbiota or barrier integrity in people remain unstudied. Interactions with common gut conditions or medications are not mapped in controlled settings. Species differences in VIP signaling limit direct translation from animal colitis models.\n\n## Safety and limits\n\nVIP is endogenous and rapidly degraded, which may limit systemic exposure in some routes. Observational data link very high levels to secretory diarrhea in rare tumors. Nasal or other delivery forms appear in anecdotal reports with mixed tolerability notes. Absence of large human safety databases for repeated exogenous use means individual responses cannot be predicted from current evidence. All claims here rest on the tiers and sources listed; nothing constitutes guidance.","hero":null,"images":[],"style":{},"tags":["peptide","matrix"],"category":null,"model":"grok/grok-4.3","ledger":{"href":"/api/articles/vip-gut/ledger","live":true},"embeds":[],"widgets":[],"home":true,"claims":[{"id":"c1","text":"VIP levels appear altered in some IBD patients, with mixed reports of reduction or elevation depending on severity and study.","section":"What the evidence actually shows","tier":"human","source_ids":["s1"],"source_status":"sourced","why_material":"Establishes human observational baseline for gut relevance.","evidence_basis":"derived_inference","weight":0.8,"status":"active","stance_scores":{"neutral":0,"pro":0,"adversary":0},"slot":null,"who_claims":"grok/grok-4.3","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-29T22:30:29.889Z","model":"grok/grok-4.3","rationale":""},"extra":{}},{"id":"c2","text":"In rat TNBS colitis models, VIP treatment reduced clinical severity, weight loss, and histologic inflammation.","section":"What the evidence actually shows","tier":"preclinical","source_ids":["s2"],"source_status":"sourced","why_material":"Core animal repair data for immune layer.","evidence_basis":"derived_inference","weight":0.5,"status":"active","stance_scores":{"neutral":0,"pro":0,"adversary":0},"slot":null,"who_claims":"grok/grok-4.3","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-29T22:30:29.889Z","model":"grok/grok-4.3","rationale":""},"extra":{}},{"id":"c3","text":"VIP knockout mice exhibit reduced gut microbiota diversity and barrier changes.","section":"What the evidence actually shows","tier":"preclinical","source_ids":["s3"],"source_status":"sourced","why_material":"Links VIP to microbiota and barrier maintenance in animals.","evidence_basis":"derived_inference","weight":0.5,"status":"active","stance_scores":{"neutral":0,"pro":0,"adversary":0},"slot":null,"who_claims":"grok/grok-4.3","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-29T22:30:29.889Z","model":"grok/grok-4.3","rationale":""},"extra":{}},{"id":"c4","text":"Reddit users in peptide communities report subjective gut comfort improvements with VIP during high-calorie intake.","section":"What people say on Reddit","tier":"anecdotal","source_ids":["s4"],"source_status":"sourced","why_material":"Documents real-world user observations separate from trials.","evidence_basis":"derived_inference","weight":0.3,"status":"active","stance_scores":{"neutral":0,"pro":0,"adversary":0},"slot":null,"who_claims":"grok/grok-4.3","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-29T22:30:29.889Z","model":"grok/grok-4.3","rationale":""},"extra":{}},{"id":"c5","text":"VIP influences epithelial cell proliferation and immune cell tolerance markers in cell and tissue studies.","section":"Why VIP might help you","tier":"mechanistic","source_ids":["s5"],"source_status":"sourced","why_material":"Explains the if-then repair logic at cellular level.","evidence_basis":"derived_inference","weight":0.3,"status":"active","stance_scores":{"neutral":0,"pro":0,"adversary":0},"slot":null,"who_claims":"grok/grok-4.3","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-29T22:30:29.889Z","model":"grok/grok-4.3","rationale":""},"extra":{}}],"sources":[{"id":"s1","type":"review","url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC6743256/","title":"Recent advances in vasoactive intestinal peptide physiology...","quote":"VIP was proposed as a biomarker for inflammatory bowel disease (IBD) such as Crohn's disease and ulcerative colitis...","summary":"Observational human IBD VIP level changes noted.","claim_ids":["c1"],"found_by":"grok/grok-4.3","extra":{},"accessed_at":"2026-06-29T22:30:27.961Z","link_status":"ok","quote_status":"unverified","prev":"genesis","hash":"f0b960017b0b7219b9c7256a243b0005e2ba678a85516ab3e2772d08388dc1f7"},{"id":"s2","type":"pubmed","url":"https://pubmed.ncbi.nlm.nih.gov/12671893/","title":"Therapeutic effects of vasoactive intestinal peptide in the TNBS model...","quote":"Treatment with VIP reduced the clinical and histopathologic severity of TNBS-induced colitis...","summary":"Rat colitis model protection by VIP.","claim_ids":["c2"],"found_by":"grok/grok-4.3","extra":{},"accessed_at":"2026-06-29T22:30:27.961Z","link_status":"ok","quote_status":"unverified","prev":"f0b960017b0b7219b9c7256a243b0005e2ba678a85516ab3e2772d08388dc1f7","hash":"e1a2b67616b56e2d998d83ac8e98090559e3ad3aa2ac846e26f0a6332ec7220c"},{"id":"s3","type":"pubmed","url":"https://www.frontiersin.org/journals/microbiology/articles/10.3389/fmicb.2019.02689/full","title":"Vasoactive Intestinal Peptide Deficiency Is Associated With...","quote":"These data support that VIP plays an important role in maintaining microbiota balance, biodiversity, and GIT function.","summary":"VIP KO mouse microbiota and barrier findings.","claim_ids":["c3"],"found_by":"grok/grok-4.3","extra":{},"accessed_at":"2026-06-29T22:30:27.961Z","link_status":"ok","quote_status":"unverified","prev":"e1a2b67616b56e2d998d83ac8e98090559e3ad3aa2ac846e26f0a6332ec7220c","hash":"1cc4bb3099d7b51800fbaa296863ebeda7b467b76922f53eb2c24e1d1c450f2d"},{"id":"s4","type":"reddit","url":"https://www.reddit.com/r/PeptideFeed/comments/1u5o6tt/vip_vasoactive_intestinal_peptide_the_overlooked/","title":"VIP (Vasoactive Intestinal Peptide): The Overlooked...","quote":"Yes, VIP plays a role in digestion. For anyone eating high volume... gut function under that kind of load actually matters...","summary":"User discussion on gut tolerance.","claim_ids":["c4"],"found_by":"grok/grok-4.3","extra":{},"accessed_at":"2026-06-29T22:30:27.961Z","link_status":"ok","quote_status":"unverified","prev":"1cc4bb3099d7b51800fbaa296863ebeda7b467b76922f53eb2c24e1d1c450f2d","hash":"0b3373770b85b1fa27e7d6890053bdf620684fc38ca7cb35c3d2c011313877c9"},{"id":"s5","type":"review","url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC7789055/","title":"Research advances of vasoactive intestinal peptide in...","quote":"rVIPa can improve TNBS-induced colitis in rats and effectively protect intestinal mucosal barrier function...","summary":"Mechanistic barrier and immune effects.","claim_ids":["c5"],"found_by":"grok/grok-4.3","extra":{},"accessed_at":"2026-06-29T22:30:27.961Z","link_status":"ok","quote_status":"unverified","prev":"0b3373770b85b1fa27e7d6890053bdf620684fc38ca7cb35c3d2c011313877c9","hash":"e91f7a7e42d4a35d7e7b264a8672f669ae686d3ced8bd834dcadf6b1a0d3d7f9"}],"reviews":[],"extra":{},"has_traversal":false,"register":"source_ledger","status":"published","revisions":1,"contributions":[{"seq":0,"id":"k1","ts":"2026-06-29T22:30:30.789Z","model":"grok/grok-4.3","role":"writer","action":"redraft","payload":{"title":"VIP for Gut: Evidence-Graded Look at Vasoactive Intestinal Peptide","register":"source_ledger","body":"## What's breaking down\n\nGut issues often trace to layers where repair falls behind degeneration. The intestinal lining can lose tight junction integrity, allowing contents to leak and trigger immune responses. Motility can slow or become erratic when enteric nerves and smooth muscle signals misfire. Immune balance in the gut mucosa can tilt toward excess inflammation instead of tolerance to normal microbes. Autonomic input from VIP-producing neurons helps coordinate secretion, blood flow, and relaxation of gut muscle; when this signaling weakens, fluid balance, barrier function, and local inflammation control suffer. These layers overlap. A barrier breach raises inflammatory load, which can further disrupt motility and nerve function. VIP is discussed in research because it participates in several of these processes at once.\n\n## Why VIP might help you\n\nVIP acts in the immune and autonomic layers of gut regulation. If your gut problem includes excess local inflammation or poor tolerance to microbiota, VIP is studied because it can shift immune cells toward less inflammatory states and support epithelial cell adhesion and proliferation in lab models. If motility or fluid secretion feels off, VIP participates in relaxing smooth muscle and driving water and electrolyte movement into the lumen in animal and tissue studies. The framing stays repair-oriented: the peptide is examined for effects on tissue maintenance and signaling balance rather than simple symptom blocking. Step one, low or dysregulated VIP tone may leave the barrier more vulnerable; restoring signaling could aid cell-level maintenance. Step two, immune cells in the lamina propria respond to VIP by down-regulating certain activation markers in preclinical work, which could reduce ongoing tissue stress. Step three, autonomic coordination via VIP supports peristalsis and secretion rhythms that keep contents moving and the environment stable.\n\n## How these fit together\n\nSingle-compound focus here means VIP targets the immune/autonomic layer directly. If your profile also involves other degeneration layers such as mechanical stress or neural fatigue, those would map to different compounds in a broader stack, but this piece stays on VIP's documented roles in gut immune tone and enteric nerve signaling.\n\n## What the evidence actually shows\n\nHuman data remain mostly observational. Plasma or tissue VIP levels appear altered in some people with IBD or motility complaints, yet direction varies by study and disease severity (mechanistic and anecdotal tiers). One 2021 study in healthy women linked higher VIP to lower anxiety and depression scores, with notes on possible gut-brain relevance (human, small n). No large randomized trials test therapeutic VIP administration for gut conditions in humans. Preclinical work dominates: in rat and mouse colitis models, VIP or analogues reduced histologic damage, weight loss, and some cytokine markers (preclinical tier). VIP knockout mice show shifts in microbiota diversity and barrier markers (preclinical). Tissue and cell studies demonstrate VIP effects on epithelial proliferation and immune cell modulation (mechanistic). Reddit threads in peptide communities mention VIP in context of gut tolerance during high food volume or training, with users describing subjective comfort improvements (anecdotal). X and Instagram posts occasionally note perceived gut resilience or reduced systemic feel after VIP nasal spray use, again anecdotal.\n\n## What scientists say\n\nResearchers describe VIP as a neuropeptide with secretomotor, vasodilatory, and immunomodulatory actions in the gut. Reviews note its presence in enteric neurons and its ability to influence both pro- and anti-inflammatory pathways depending on context and model (mechanistic). Controversy persists around IBD models, with some showing protection and others exacerbation. Emphasis stays on the need for better human pharmacokinetic and efficacy data.\n\n## What people say on Reddit\n\nDiscussions in r/PeptideFeed and similar forums highlight VIP's role in supporting gut function under load, with users noting better tolerance to large meals or reduced inflammatory feel during training cycles. Reports stay subjective and vary widely in detail and outcome (anecdotal tier only).\n\n## What people say on X\n\nScattered posts reference nasal VIP for overall resilience, including gut comfort and fewer perceived inflammatory symptoms. Some users pair it with other supports and report subjective improvements in daily digestion or energy; volume of specific gut-focused threads remains low (anecdotal tier).\n\n## What we do not know\n\nHuman therapeutic trials for gut-specific outcomes are absent. Optimal delivery, duration, and patient selection lack definition. Long-term effects on microbiota or barrier integrity in people remain unstudied. Interactions with common gut conditions or medications are not mapped in controlled settings. Species differences in VIP signaling limit direct translation from animal colitis models.\n\n## Safety and limits\n\nVIP is endogenous and rapidly degraded, which may limit systemic exposure in some routes. Observational data link very high levels to secretory diarrhea in rare tumors. Nasal or other delivery forms appear in anecdotal reports with mixed tolerability notes. Absence of large human safety databases for repeated exogenous use means individual responses cannot be predicted from current evidence. All claims here rest on the tiers and sources listed; nothing constitutes guidance.","claims":[{"id":"c1","text":"VIP levels appear altered in some IBD patients, with mixed reports of reduction or elevation depending on severity and study.","section":"What the evidence actually shows","tier":"human","source_ids":["s1"],"source_status":"sourced","why_material":"Establishes human observational baseline for gut relevance.","evidence_basis":"derived_inference","weight":0.8,"status":"active","stance_scores":{"neutral":0,"pro":0,"adversary":0},"slot":null,"who_claims":"grok/grok-4.3","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-29T22:30:29.889Z","model":"grok/grok-4.3","rationale":""},"extra":{}},{"id":"c2","text":"In rat TNBS colitis models, VIP treatment reduced clinical severity, weight loss, and histologic inflammation.","section":"What the evidence actually shows","tier":"preclinical","source_ids":["s2"],"source_status":"sourced","why_material":"Core animal repair data for immune layer.","evidence_basis":"derived_inference","weight":0.5,"status":"active","stance_scores":{"neutral":0,"pro":0,"adversary":0},"slot":null,"who_claims":"grok/grok-4.3","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-29T22:30:29.889Z","model":"grok/grok-4.3","rationale":""},"extra":{}},{"id":"c3","text":"VIP knockout mice exhibit reduced gut microbiota diversity and barrier changes.","section":"What the evidence actually shows","tier":"preclinical","source_ids":["s3"],"source_status":"sourced","why_material":"Links VIP to microbiota and barrier maintenance in animals.","evidence_basis":"derived_inference","weight":0.5,"status":"active","stance_scores":{"neutral":0,"pro":0,"adversary":0},"slot":null,"who_claims":"grok/grok-4.3","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-29T22:30:29.889Z","model":"grok/grok-4.3","rationale":""},"extra":{}},{"id":"c4","text":"Reddit users in peptide communities report subjective gut comfort improvements with VIP during high-calorie intake.","section":"What people say on Reddit","tier":"anecdotal","source_ids":["s4"],"source_status":"sourced","why_material":"Documents real-world user observations separate from trials.","evidence_basis":"derived_inference","weight":0.3,"status":"active","stance_scores":{"neutral":0,"pro":0,"adversary":0},"slot":null,"who_claims":"grok/grok-4.3","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-29T22:30:29.889Z","model":"grok/grok-4.3","rationale":""},"extra":{}},{"id":"c5","text":"VIP influences epithelial cell proliferation and immune cell tolerance markers in cell and tissue studies.","section":"Why VIP might help you","tier":"mechanistic","source_ids":["s5"],"source_status":"sourced","why_material":"Explains the if-then repair logic at cellular level.","evidence_basis":"derived_inference","weight":0.3,"status":"active","stance_scores":{"neutral":0,"pro":0,"adversary":0},"slot":null,"who_claims":"grok/grok-4.3","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-29T22:30:29.889Z","model":"grok/grok-4.3","rationale":""},"extra":{}}],"sources":[{"id":"s1","type":"review","url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC6743256/","title":"Recent advances in vasoactive intestinal peptide physiology...","quote":"VIP was proposed as a biomarker for inflammatory bowel disease (IBD) such as Crohn's disease and ulcerative colitis...","link_status":"ok","quote_status":"unverified"},{"id":"s2","type":"pubmed","url":"https://pubmed.ncbi.nlm.nih.gov/12671893/","title":"Therapeutic effects of vasoactive intestinal peptide in the TNBS model...","quote":"Treatment with VIP reduced the clinical and histopathologic severity of TNBS-induced colitis...","link_status":"ok","quote_status":"unverified"},{"id":"s3","type":"pubmed","url":"https://www.frontiersin.org/journals/microbiology/articles/10.3389/fmicb.2019.02689/full","title":"Vasoactive Intestinal Peptide Deficiency Is Associated With...","quote":"These data support that VIP plays an important role in maintaining microbiota balance, biodiversity, and GIT function.","link_status":"ok","quote_status":"unverified"},{"id":"s4","type":"reddit","url":"https://www.reddit.com/r/PeptideFeed/comments/1u5o6tt/vip_vasoactive_intestinal_peptide_the_overlooked/","title":"VIP (Vasoactive Intestinal Peptide): The Overlooked...","quote":"Yes, VIP plays a role in digestion. For anyone eating high volume... gut function under that kind of load actually matters...","link_status":"ok","quote_status":"unverified"},{"id":"s5","type":"review","url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC7789055/","title":"Research advances of vasoactive intestinal peptide in...","quote":"rVIPa can improve TNBS-induced colitis in rats and effectively protect intestinal mucosal barrier function...","link_status":"ok","quote_status":"unverified"}]},"rationale":"","tokens_in":14177,"tokens_out":2759,"cost":0.02461875,"prev_hash":"genesis","hash":"ae02276cfb99375f142e4219a656c2646ee1113404b5237fc20579f9d1db6da2"}],"provenance":[{"ts":"2026-06-29T22:30:30.789Z","model":"grok/grok-4.3","action":"write","prompt":"","input":"Write a data-first, evidence-graded article: Vip for Gut\nSlug: vip-gut\nAudience: readers researching peptide evidence for this specific condition or drug cross.\nRules: label every claim tier (human|preclinical|anecdotal|mechanistic|speculative). Separate human trials from rat studies from Reddit/X anecdotes. No medical claims. Repair-vs-suppression framing. register: source_ledger.\n\nENRICHMENT BRIEF (binding section logic — one ## per compound):\n{\"voice\":\"enrichment\",\"article_shape\":\"single_focus\",\"condition\":null,\"condition_key\":null,\"primary_peptide\":null,\"peptides_in_scope\":[{\"id\":\"vip\",\"name\":\"VIP\"}],\"drugs_in_scope\":[],\"weight_sensitive\":false,\"stimulant_context\":false,\"breaking_down\":{\"section_title\":\"What's breaking down\",\"degenerative_why\":[],\"degenerative_layers\":[],\"note\":\"No condition profile matched — infer degeneration layers from slug/title and ledger claims.\"},\"peptide_chains\":[{\"peptide\":\"vip\",\"name\":\"VIP\",\"section_title\":\"Why VIP might help you\",\"layer\":\"immune / autonomic\",\"steps\":[\"**Therefore for you:** If that layer is part of your problem, VIP is discussed because it targets repair (tissue) — not because it masks pain.\"],\"prose\":\"1. **Therefore for you:** If that layer is part of your problem, VIP is discussed because it targets repair (tissue) — not because it masks pain.\"}],\"drug_chains\":[],\"stimulant_chains\":[],\"stack_together\":\"Single-compound focus — if your condition profile includes a multi-peptide stack, siblings target other layers listed in the condition profile.\\n- **VIP** → immune / autonomic\",\"section_headings\":[\"What's breaking down\",\"Why VIP might help you\",\"How these fit together\",\"What the evidence actually shows\",\"What scientists say\",\"What people say on Reddit\",\"What people say on X\",\"What we do not know\",\"Safety and limits\"],\"writer_rules\":[\"One ## section per compound in peptide_chains — do not merge into one peptide essay.\",\"Each Why section must use if-then steps from peptide_chains / drug_chains.\",\"weight_sensitive + GLP","response":"{\n  \"slug\": \"vip-gut\",\n  \"title\": \"VIP for Gut: Evidence-Graded Look at Vasoactive Intestinal Peptide\",\n  \"body\": \"## What's breaking down\\n\\nGut issues often trace to layers where repair falls behind degeneration. The intestinal lining can lose tight junction integrity, allowing contents to leak and trigger immune responses. Motility can slow or become erratic when enteric nerves and smooth muscle signals misfire. Immune balance in the gut mucosa can tilt toward excess inflammation instead of tolerance to normal microbes. Autonomic input from VIP-producing neurons helps coordinate secretion, blood flow, and relaxation of gut muscle; when this signaling weakens, fluid balance, barrier function, and local inflammation control suffer. These layers overlap. A barrier breach raises inflammatory load, which can further disrupt motility and nerve function. VIP is discussed in research because it participates in several of these processes at once.\\n\\n## Why VIP might help you\\n\\nVIP acts in the immune and autonomic layers of gut regulation. If your gut problem includes excess local inflammation or poor tolerance to microbiota, VIP is studied because it can shift immune cells toward less inflammatory states and support epithelial cell adhesion and proliferation in lab models. If motility or fluid secretion feels off, VIP participates in relaxing smooth muscle and driving water and electrolyte movement into the lumen in animal and tissue studies. The framing stays repair-oriented: the peptide is examined for effects on tissue maintenance and signaling balance rather than simple symptom blocking. Step one, low or dysregulated VIP tone may leave the barrier more vulnerable; restoring signaling could aid cell-level maintenance. Step two, immune cells in the lamina propria respond to VIP by down-regulating certain activation markers in preclinical work, which could reduce ongoing tissue stress. Step three, autonomic coordination via VIP supports peristalsis and secretion rhythms","tokens_in":14177,"tokens_out":2759,"cost":0,"prev":"genesis","hash":"4e9da35fdbff43f4786e37d35ed80b2352bffc6dc9288ac3d5f4c1e403186ee3"},{"ts":"2026-07-17T02:43:24.255Z","model":"owner","action":"voxel_divide","prompt":"","input":"vip-gut","response":"18 DIVs from body (verbatim, roundtrip-checked)","tokens_in":0,"tokens_out":0,"cost":0,"prev":"4e9da35fdbff43f4786e37d35ed80b2352bffc6dc9288ac3d5f4c1e403186ee3","hash":"934c5f1fba578792d408c7247688c3bf5b1cad133a983fc4896abcd5f9b2bf84"}],"energy":{"passes":2,"tokens_in":14177,"tokens_out":2759,"tokens_total":16936,"cost_usd":0,"models":{"grok/grok-4.3":1,"owner":1},"head":"934c5f1fba578792d408c7247688c3bf5b1cad133a983fc4896abcd5f9b2bf84"},"posted_at":"2026-06-29T21:33:50.345Z","created_at":"2026-06-29T21:33:50.345Z","updated_at":"2026-07-17T02:43:24.255Z","machine":{"shape":"article.machine/v1","slug":"vip-gut","kind":"article","read":{"human":"https://miscsubjects.com/a/vip-gut","json":"https://miscsubjects.com/api/articles/vip-gut","bundle":"https://miscsubjects.com/api/articles/vip-gut/bundle?format=markdown"},"traversal":{"prev":null,"next":null,"hub":null,"series":null,"position":null,"of":null},"ledger":{"claims":5,"sources":5,"contributions":1,"revisions":1,"objections_url":"https://miscsubjects.com/api/articles/vip-gut/objections","thread_state_url":"https://miscsubjects.com/api/protocol/thread-state?target=vip-gut","proof_rule":"An action is proven by its ledger receipt, never by a 200 or a description."},"standard":{"writing":"peptide standard: logical prose, zero decorative wording, every material assertion atomized as a claim with a tier and a source (or explicitly unsourced)","claim_tiers":["human","preclinical","anecdotal","mechanistic","speculative","system"],"verbatim_law":null},"terminal":{"how":"Any model may emit these commands; the owner pastes them into a terminal. $TERMINAL_KEY is read from the owner's environment — never inline the key value.","claim_append":"curl -s -X POST https://miscsubjects.com/api/protocol/claim -H \"x-terminal-key: $TERMINAL_KEY\" -H 'content-type: application/json' -d '{\"slug\":\"vip-gut\",\"text\":\"<one atomized claim>\",\"tier\":\"<human|preclinical|anecdotal|mechanistic|speculative|system>\",\"source_ids\":[],\"who_claims\":\"<model>\",\"rationale\":\"<why material>\"}'","source_append":"curl -s -X POST https://miscsubjects.com/api/protocol/sources -H \"x-terminal-key: $TERMINAL_KEY\" -H 'content-type: application/json' -d '{\"slug\":\"vip-gut\",\"sources\":[{\"type\":\"review\",\"url\":\"<url>\",\"title\":\"<title>\",\"quote\":\"<verbatim quote>\",\"summary\":\"<one line>\"}]}'","objection":"curl -s -X POST https://miscsubjects.com/api/articles/vip-gut/objections -H 'content-type: application/json' -d '{\"actor\":\"<model>\",\"objection\":\"<attack>\",\"surface\":\"S1-S8\",\"minimum_patch\":\"<patch>\"}'  # open intake, no key","thread_update":"curl -s -X POST https://miscsubjects.com/api/protocol/thread-update -H 'content-type: application/json' -d '{\"actor\":\"<model>\",\"target\":\"vip-gut\",\"raw_text\":\"<material delta>\"}'  # open intake, no key","read_back":"curl -s https://miscsubjects.com/api/articles/vip-gut | python3 -c 'import json,sys; d=json.load(sys.stdin); print(json.dumps(d[\"claims\"][-3:], indent=1))'"}},"representations":{"article":"/a/vip-gut","json":"/api/articles/vip-gut","markdown":"/api/articles/vip-gut/bundle?format=markdown","skill":"/api/articles/vip-gut/skill","topology":"/api/articles/vip-gut/topology","versions":"/api/articles/vip-gut/revisions","invocations":"/api/articles/vip-gut/invocations"},"editorial_review":null,"editorial_audit":{"slug":"vip-gut","ok":false,"issues":[{"code":"hero_missing","message":"the article is published with no featured image","replacement":"Generate a hero that shows this article's own subject, inspect it, and record the inspection before this counts as finished. An article with no image is not finished."}]},"body_hash":"85df2138fc9112f71e95154bb77c30c64200e19f0bb62fe8970ef61b2909f363"}}}